Disorders of salt and fluid balance: Diabetes insipidus, cerebral salt-wasting syndrome, and syndrome of inappropriate antidiuresis

Hormones, Brain and Behavior Online

Volumn , Issue , 2009, Pages 3235-3267

  Lenhard, T ^a   Bettendorf, M ^a   Schwab, S ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Aquaporin; Countercurrent mechanism; Diabetes insipidus; Fluid balance; Inappropriate antidiuresis; Natriuretic peptides; Nephron; Salt; Salt wasting; Subarachnoid hemorrhage; Urine concentration; Vasopressin

Indexed keywords

EID: 84884764344     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008088783-8.00102-9     Document Type: Chapter

References (71)

1. Adrogue H.J., Madias N. Hypernatremia. New England Journal of Medicine 2000, 342:1493-1499.
2. Albanese A., Hindmarsh P., Stanhope R. Management of hyponatraemia in patients with acute cerebral insults. Archives of Disease in Childhood 2001, 85:246-251.
3. Alpert R.J., Hebert S.C. Seldin and Giebisch's The Kidney: Physiology and Pathophysiology 2007, Elsevier, St. Louis, MO. 4th edn.
4. Antunes-Rodrigues J., de Castro M., Elias L.L., Valença M.M., McCann S.M. Neuroendocrine control of body fluid metabolism. Physiological Reviews 2004, 84:169-208.
5. Beitz E., Wu B., Holm L.M., Schultz J.E., Zeuthen T. Point mutations in the aromatic/arginine region in aquaporin 1 allow passage of urea, glycerol, ammonia, and protons. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:269-274.
6. Berendes E., Walter M., Cullen P., et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 1997, 349:245-249.
7. Berger T.M., Kistler W., Berendes E., Raufhake C., Walter M. Hyponatremia in a pediatric stroke patient: Syndrome of inappropriate antidiuretic hormone secretion or cerebral salt wasting?. Critical Care Medicine 2002, 30:792-795.
8. Bernier V., Morello J.P., Zarruk A., et al. Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. Journal of the American Society of Nephrology 2006, 17:232-243.
9. Calado J., Loeffler J., Sakallioglu O., Gok F., Lhotta K., Barata J., RueffJ. Familial renal glucosuria: SLC5A2 mutation analysis and evidence of salt-wasting. Kidney International 2006, 69:852-855.
10. Cao L., Joshi P., Sumoza D. Renal salt-wasting syndrome in a patient with cisplatin-induced hyponatremia: Case report. American Journal of Clinical Oncology 2002, 25:344-346.
11. Cheetham T., Baylis P.H. Diabetes insipidus in children: Pathophysiology, diagnosis and management. Paediatric Drugs 2002, 4:785-796.
12. Christ-Crain M., Müller B. Biomarkers in respiratory tract infections: Diagnostic guides to antibiotic prescription, prognastic markers and mediators. European Respiratory Journal 2007, 30:556-573.
13. Christensen J.H., Rittig S. Familial neurohypophyseal diabetes insipidus: An update. Seminars in Nephrology 2006, 26:209-223.
14. Constanzo L.S. Physiology 2006, 235-299. ch. 5, Saunders Elsevier, Philadelphia, PA. 3rd edn.
15. Ellison D.H., Berl T. The syndrome of inappropriate antidiuresis. New England Journal of Medicine 2007, 356:2064-2072.
16. Funder J.W. The role of aldosterone and mineralocorticoid receptors in cardiovascular disease. American Journal of Cardiovascular Drugs 2007, 7:151-157.
17. Garofeanu C.G., Weir M., Rosas-Arellano M.P., Henson G., Garg A.X., Clark W.F. Causes of reversible nephrogenic diabetes insipidus: A systematic review. American Journal of Kidney Diseases 2005, 45:626-637.
18. Ghirardello S., Garrè M.L., Rossi A., Maghnie M. The diagnosis of children with central diabetes insipidus. Journal of Pediatric Endocrinology and Metabolism 2007, 20:359-375.
19. Ghirardello S., Malattia C., Scagnelli P., Maghnie M. Current perspective on the pathogenesis of central diabetes insipidus. Journal of Pediatric Endocrinology and Metabolism 2005, 18:631-645.
20. Gurrera R.J. Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome. American Journal of Psychiatry 1999, 156:169-180.
21. Halperin M.L., Bichet D.G., Oh M.S. Integrative physiology of basal water permeability in the distal nephron: Implications for the syndrome of inappropriate secretion of antidiuretic hormone. Clinical Nephrology 2001, 56:339-345.
22. Halperin M.L., Kamel K.S. A new look at an old problem: Therapy of chronic hyponatremia. Nature Clinical Practice Nephrology 2007, 3:[2]-3.
23. Harrigan M.R. Cerebral salt wasting syndrome: A review. Neurosurgery 1996, 38:152-160.
24. Harrigan M.R. Cerebral salt wasting syndrome. Critical Care Clinics 2001, 17:125-138.
25. Hu X., Funder J.W. The evolution of mineralocorticoid receptors. Molecular Endrocrinology 2005, 20:1471-1478.
26. King L.S., Kozono D., Agre P. From structure to disease: The evolving tale of aquaporin biology. Nature Reviews Molecular Cell Biology 2004, 5:687-698.
27. Kurokawa Y., Uede T., Ishiguro M., Honda O., Honmou O., Kato T., Wanibuchi M. Pathogenesis of hyponatremia following subarachnoid hemorrhage due to ruptured cerebral aneurysm. Surgical Neurology 1996, 46:500-507.
28. Lenhard T., Külkens S., Schwab S. Cerebral salt-wasting syndrome in a patient with neuroleptic malignant syndrome. Archives of Neurology 2007, 64:122-125.
29. Levine J.P., Stelnicki E., Weiner H.L., Bradley J.P., McCarthy J.G. Hyponatremia in the postoperative craniofacial pediatric patient population: A connection to cerebral salt wasting syndrome and management of the disorder. Plastic and Reconstructive Surgery 2001, 108:1501-1508.
30. Lien Y.-H.H., Shapiro J.I. Hyponatremia: Clinical diagnosis and management. American Journal of Medicine 2007, 120:653-658.
31. Maesaka J.K., Gupta S., Fishbane S. Cerebral salt-wasting syndrome: Does it exist?. Nephron 1999, 82:100-109.
32. Maesaka J.K., Miyawaki N., Palaia T., Fishbane S., Durham J.H. Renal salt wasting without cerebral disease: Diagnostic value of urate determinations in hyponatremia. Kidney International 2007, 71:822-826.
33. Maghnie M. Diabetes insipidus. Hormone Research 2003, 59(supplement):42-54.
34. Maghnie M., Ghirardello S., DeBellis A., et al. Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin-cell antibodies and markers of autoimmunity. Clinical Endocrinology (Oxf) 2006, 65:470-478.
35. Magner P.O., Halperin M.L. Polyuria - a pathophysiological approach. North American Medical 1987, 15:2987-2997.
36. Morello J.P., Bichet D.G. Nephrogenic diabetes insipidus. Annual Review of Physiology 2001, 63:607-630.
37. Morello J.P., Salahpour A., Laperrière A., et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. Journal of Clinical Investigation 2000, 105:887-895.
38. Nguyen M.K., Nielsen S., Kurtz I. Molecular pathogenesis of nephrogenic diabetes insipidus. Clinical and Experimental Nephrology 2003, 7:9-17.
39. Nicchia G.P., Frigeri A., Liuzzi G.M., Svelto M. Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genes. FASEB Journal 2003, 17:1508-1510.
40. Oh M.S. Management of hyponatremia and clinical use of vasopressin antagonists. American Journal of the Medical Sciences 2007, 333:101-105.
41. Palmer B.F. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends in Endocrinology and Metabolism 2003, 14:182-187.
42. Peters J.P., Welt L.G., Sims E.A., OrloffJ., Needham J. A salt-wasting syndrome associated with cerebral disease. Transactions of the Association of American Physicians 1950, 63:57-64.
43. Rabinstein A.A., Wijdicks E.F. Hyponatremia in critically ill neurological patients. Neurologist 2003, 9:290-300.
44. Rivkees S.A., Dunbar N., Wilson T.A. The management of central diabetes insipidus in infancy: Desmopressin, low renal solute load formula, thiazide diuretics. Journal of Pediatric Endocrinology and Metabolism 2007, 20:459-469.
45. Robben J.H., Deen P.M. Pharmacological chaperones in nephrogenic diabetes insipidus: Possibilities for clinical application. BioDrugs 2007, 21:157-166.
46. Robben J.H., Knoers N.V., Deen P.M. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. American Journal of Physiology - Renal Physiology 2006, 291:F257-F270.
47. Robertson G.L. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. American Journal of Medicine 2006, 119(supplement 1):S36-S42.
48. Ropper A.H., Wijdicks E.F., Truax B.T. Guillain-Barre' Syndrome 1991, FA Davis Company, Philadelphia, PA.
49. Roudier N., Ripoche P., Gane P., Le Pennec P.Y., Daniels G., Cartron J.P., Bailly P. AQP3 deficiency in humans and the molecular basis of a novel blood group system, GIL. Journal of Biological Chemistry 2002, 277:45854-45859.
50. Schrier R.W., Martin P.Y. Recent advances in the understanding of water metabolism in heart failure. Advances in Experimental Medicine and Biology 1998, 449:415-426.
51. Schwartz W.B., Bennett W., Curelop S., Bartter F.C. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. American Journal of Medicine 1957, 23:529-542.
52. Shaffrey M.E., Shaffrey C., Lanzino G. Nonoperative treatment of aneurysmal subarachnoid hemorrhage. Neurological Surgery 1996, 1264-1271. W. B. Saunders, Philadelphia, PA. 4th edn. J.R. Youmans (Ed.).
53. Traggiai C., Stanhope R. Endocrinopathies associated with midline cerebral and cranial malformations. Journal of Pediatrics 2002, 140:252-255.
54. von Bismarck P., Ankermann T., Eggert P., Claviez A., Fritsch M.J., Krause M.F. Diagnosis and management of cerebral salt wasting (CSW) in children: The role of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP). Child's Nervous System 2006, 22:1275-1281.
55. Wehling M. Effects of aldosterone and mineralocorticoid receptor blockade on intracellular electrolytes. Heart Failure Reviews 2005, 10:39-46.
56. Wijdicks E.F., Ropper A.H., Hunnicutt E.J., Richardson G.S., Nathanson J.A. Atrial natriuretic factor and salt wasting after aneurysmal subarachnoid hemorrhage. Stroke 1991, 22:1519-1524.
57. Wijdicks E.F., Vermeulen M., ten Haaf J.A., Hijdra A., Bakker W.H., van Gijn J. Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Annals of Neurology 1985, 18:211-216.
58. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurology 2007, 6:805-815.
59. Deen P.M., Verdijk M.A., Knoers N.V., Wieringa B., Monnens L.A., van Os C.H., van Oost B.A. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 1994, 264:92-95.
60. Funder J.W. Aldosterone and mineralocorticoid receptors: Orphan questions. Kidney International 2000, 57:358-363.
61. Hobbs H.H., Russell D.W., Brown M.S., Goldstein J.L. The LDL receptor locus in familial hypercholesterolemia: Mutational analysis of a membrane protein. Annual Review of Genetics 1990, 24:133-170.
62. King L.S., Choi M., Fernandez P.C., Cartron J.P., Agre P. Defective urinary-concentrating ability due to a complete deficiency of aquaporin-1. New England Journal of Medicine 2001, 345:175-179.
63. Lang F. Mechanisms and significance of cell volume regulations. Contributions to Nephrology 2006, vol. 152:1-8. Karger, Basel. C. Ronco (Ed.).
64. Mizobuchi M., Kunishige M., Kubo K., Komatsu M., Bando H., Saito S. Syndrome of inappropriate secretion of ADH (SIADH) due to small cell lung cancer with extremely high plasma vasopressin level. Internal Medicine 1994, 33:501-504.
65. Moller K., Larsen F.S., Bie P., Skinhoj P. The syndrome of inappropriate secretion of antidiuretic hormone and fluid restriction in meningitis - how strong is the evidence?. Scandinavian Journal of Infectious Diseases 2001, 33:13-26.
66. Papadopoulos M.C., Verkman A.S. Aquaporin-4 and brain edema. Pediatric Nephrology 2007, 22:778-784.
67. Potter L.R., Abbey-Hosch S., Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocrine Reviews 2006, 27:47-72.
68. Preston G.M., Smith B.L., Zeidel M.L., Moulds J.J., Agre P. Mutations in aquaporin-1 in phenotypically normal humans without functional CHIP water channels. Science 1994, 265:1585-1587.
69. Salvatoni A., Maghnie M., Lorini R., Marni E. Hyponatremia and seizures during desmopressin acetate treatment in hypothyroidism. Journal of Pediatrics 1990, 116:835-836.
70. Sanghvi S.R., Kellerman P.S., Nanovic L. Beer potomania: An unusual cause of hyponatremia at high risk of complications from rapid correction. American Journal of Kidney Diseases 2007, 50:673-680.
71. Verkman A.S., Binder D.K., Bloch O., Auguste K., Papadopoulos M.C. Three distinct roles of aquaporin-4 in brain function revealed by knockout mice. Biochimica et Biophysica Acta 2006, 1758:1085-1093.